DOCSLIB.ORG

Low-Level Night-Time Light Therapy for Age-Related Macular Degeneration

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Low-Level Night-Time Light Therapy for Age-Related Macular Degeneration School of Optometry and Vision Sciences Cardiff University Low-Level Night-Time Light Therapy for Age-Related Macular Degeneration David Grant Robinson 2017 A thesis submitted to Cardiff University for the degree of Doctor of Philosophy Supervisors: AM Binns TH Margrain Advisor: A Wood For Catherine i Declaration This work has not been submitted in substance for any other degree or award at this or any other university or place of learning, nor is being submitted concurrently in candidature for any degree or other award. Signed: (candidate) Date: 11/9/2017 STATEMENT 1 This thesis is being submitted in partial fulfilment of the requirements for the degree of PhD. Signed: (candidate) Date: 11/9/2017 STATEMENT 2 This thesis is the result of my own independent work/investigation, except where otherwise stated, and the thesis has not been edited by a third party beyond what is permitted by Cardiff University’s Policy on the Use of Third Party Editors by Research Degree Students. Other sources are acknowledged by explicit references. The views expressed are my own. Signed: (candidate) Date: 11/9/2017 STATEMENT 3 I hereby give consent for my thesis, if accepted, to be available online in the University’s Open Access repository and for inter-library loan, and for the title and summary to be made available to outside organisations. Signed: (candidate) Date: 11/9/2017 ii Acknowledgements Firstly, I would like to thank my two inspirational supervisors, Dr Ali Binns and Prof Tom Margrain for their guidance and encouragement throughout this PhD. I would also like to thank Dr Ashley Wood and Dr Matt Dunn for their help and advice over the years. Many thanks also go to the office staff at the Optometry department, especially the wonderful Sue Hobbs who has provided fantastic support since day one. A huge thank you to everyone in the Bristol Eye Hospital Clinical Research and Retinal Imaging Units for all of the hard work you have contributed to this PhD. In particular, I would like to thank Ms Clare Bailey and my fantastic trial manager Gemma Brimson. I would also like to extend my gratitude to all of the participants that agreed to take part in my studies. A heartfelt thanks goes to my fellow post-graduate friends, especially those in office 2.10. Thank you all for putting up with my distracting antics and grumpiness over the last 3 years. A special thanks goes to Nikki Cassels, who has been a constant source of encouragement and friendship since we first sat next to each other in 2013. Finally, I would like to express my love and gratitude to my family. Especially to my wife Catherine, my parents, my siblings and to David for their enduring support and encouragement. You have always believed in me, for which I will forever be grateful. iii Table of contents Dedication…………………………………………………………………………………...i Declaration.... .......................................................................................................... ii Acknowledgements ............................................................................................... iii Table of contents ................................................................................................... iv List of tables .......................................................................................................... xi List of figures ...................................................................................................... xiii Acronyms……..................................................................................................... xvii Summary……. ....................................................................................................... xx Chapter 1. Introduction ....................................................................................... 1 1.1. Normal retinal structure .............................................................................. 1 Blood supply to the retina .................................................................... 3 The effect of luminance on retinal oxygen demand ............................. 5 Bruch’s membrane .............................................................................. 7 The retinal pigment epithelium ............................................................ 7 The photoreceptor layer ...................................................................... 9 1.2. Light and dark retinal physiology .............................................................. 11 Visual phototransduction cascade ..................................................... 12 Recycling of visual pigment ............................................................... 13 Alternative method of visual pigment regeneration ............................ 15 The dark current ................................................................................ 16 1.3. Age-related macular degeneration ........................................................... 17 Risk factors for AMD ......................................................................... 19 iv AMD pathogenesis ........................................................................... 23 Clinical features of AMD ................................................................... 27 AMD grading scales ......................................................................... 32 Prevention and treatment ................................................................. 35 Clinical investigation of AMD ............................................................ 41 1.4. Visual psychophysics ............................................................................... 52 Classical psychophysical methods.................................................... 52 Adaptive psychophysical methods .................................................... 54 1.5. PhD objectives ......................................................................................... 58 Pilot study aims ................................................................................ 58 Cross-sectional study aims ............................................................... 59 Longitudinal clinical trial (the ALight trial) aims ................................. 59 1.6. Conclusion ............................................................................................... 60 Chapter 2. Evaluating the role of hypoxia in the pathogenesis of AMD: a literature review ................................................................................................... 61 2.1. Introduction .............................................................................................. 61 2.2. Literature review methods ....................................................................... 63 Literature searching methods ........................................................... 64 2.3. Results .................................................................................................... 65 Direct evidence of hypoxia in AMD ................................................... 66 2.4. Indirect evidence of hypoxia in AMD ........................................................ 70 Choroidal blood flow volume and velocity ......................................... 70 Structural changes to the choroid ..................................................... 72 v Changes to choroidal blood flow perfusion ........................................ 74 Bruch’s membrane and RPE dysfunction .......................................... 76 Mitochondrial damage ....................................................................... 78 2.5. Discussion ................................................................................................ 79 Chapter 3. General methods and protocol development ................................ 82 3.1. Overview of original protocol .................................................................... 82 3.1.1. Primary outcome measures ............................................................... 83 3.1.2. Secondary outcome measures .......................................................... 85 3.1.3. Participant eligibility criteria ............................................................... 86 3.1.4. Recruitment strategy ......................................................................... 87 3.1.5. Withdrawal from trial: criteria and loss to follow-up ............................ 88 3.1.6. Registration ....................................................................................... 88 3.2. Intervention .............................................................................................. 88 Determining the optimum light level for the intervention .................... 91 Maintenance of the light level ............................................................ 92 Circadian rhythm ............................................................................... 93 Ocular position during sleep .............................................................. 94 3.3. Trial procedures ....................................................................................... 95 Informed consent and screening ....................................................... 95 Screening assessment ...................................................................... 95 Baseline assessment ........................................................................ 96 Enrolment .......................................................................................... 99 Monthly assessment of medical records ............................................ 99 vi Monthly follow-up
Load more

Recommended publications
  • Characterising Adaptational Dysfunction in Age-Related Macular Degeneration
    Characterising adaptational dysfunction in age-related macular degeneration A thesis submitted to Cardiff University for the degree of Doctor of Philosophy By Allannah Jayne Gaffney School of Optometry and Vision Sciences Cardiff University August 2012 Supervised by Dr Alison Binns and Dr Tom Margrain Summary Age-related macular degeneration (AMD) is the leading cause of visual impairment in the developed world (Resnikoff et al., 2004). The prevalence of this disease will continue to increase over the coming decades as the average age of the global population rises (United Nations, 2009). There is consequently an urgent need to develop tests that are sensitive to early visual dysfunction, in order to identify individuals that have a high risk of developing AMD, to identify patients that would benefit from treatment, to assess the outcomes of that treatment and to evaluate emerging treatment strategies. An emerging body of evidence suggests that dark adaptation is a sensitive biomarker for early AMD. Cone dark adaptation is of particular interest to clinicians, as it can identify patients with early AMD in a relatively short recording period. Consequently, this thesis aimed to optimise psychophysical and electrophysiological techniques for the assessment of cone dark adaptation in early AMD, in order to maximise its diagnostic potential. A range of psychophysical methods were shown to be capable of monitoring the rapid changes in threshold that occur during cone dark adaptation. An optimal psychophysical protocol for the assessment of cone dark adaptation in early AMD was developed based on the results of a systematic evaluation of the effect of stimulus parameters and pre-adapting light intensity on the diagnostic potential of cone dark adaptation in early AMD.
    [Show full text]
  • Visual Predictors for Poor Mobility Performance in People with Age Related Macular Degeneration
    VISUAL PREDICTORS FOR POOR MOBILITY PERFORMANCE IN PEOPLE WITH AGE RELATED MACULAR DEGENERATION Remy Sheena Mathew, B.Sc A thesis submitted in partial fulfilment of the requirements for admission to the degree of Doctor of Philosophy School of Optometry and Vision Science, University of New South Wales, Sydney, Australia September 2009 Visual predictors for poor mobility performance in people with AMD Originality statement ‘I hereby declare that this submission is my own work and to the best of my knowledge it contains no materials previously published or written by another person, or substantial proportions of material which have been accepted for the award of any other degree or diploma at UNSW or any other educational institution, except where due acknowledgement is made in the thesis. Any contribution made to the research by others, with whom I have worked at UNSW or elsewhere, is explicitly acknowledged in the thesis. I also declare that the intellectual content of this thesis is the product of my own work, except to the extent that assistance from others in the project's design and conception or in style, presentation and linguistic expression is acknowledged.’ Signed …………………………...................... Remy Sheena Mathew. ii Visual predictors for poor mobility performance in people with AMD Copyright and Authenticity Statements COPYRIGHT STATEMENT ‘I hereby grant the University of New South Wales or its agents the right to archive and to make available my thesis or dissertation in whole or part in the University libraries in all forms of media, now or here after known, subject to the provisions of the Copyright Act 1968.
    [Show full text]
  • Normative Value of Photostress Recovery Time Among Various Age Groups in Southern India
    Medical Hypothesis, Discovery &Innovation Optometry Journal Original Article Normative value of photostress recovery time among various age groups in southern India Bhandari Bishwash 1 , De Tapas Kumar 1, Sah Sanjay Kumar 1, Sanyam Sandip Das 1 1 Sankara Academy of Vision, Sankara College of optometry, Bangalore, India ABSTRACT Background: To determine the normative data and reference value for photostress recovery time (PSRT) following exposure of the macula to light, in various age groups within the Indian population. Methods: Cross-sectional observational study performed from November 2015 to July 2016 in the Bangalore district of Karnataka state in India. We examined a total of 1,282 eyes of 641 participants and included those with corrected distance visual acuity (CDVA) scoes lower than or equal to 0.4 Logarithm of the Minimum Angle of Resolution (LogMAR). We performed the photostress procedure under standard conditions using the same approach. Results: The mean ± standard deviation (SD) of the participants’ age was 32.04 ± 15.80, with an age range of 8 to 70 years. The PSRT in participants below 16 years and above 45 years of age were significantly different compared to the 16–25-year-old age group (P < 0.0001 for both). The PSRT values were significantly different between males and females in the reproductive age group (16 to 45 years old) (P < 0.0001), but not in the other age groups. Conclusions: The PSRT values were significantly different in children and older patients compared to the 16 to 25 years age group. We found that as age increased, PSRT increased significantly.
    [Show full text]
  • The Development of a Clinical Trial Protocol and Functional Biomarkers for Age-Related Macular Degeneration
    The Development of a Clinical Trial Protocol and Functional Biomarkers for Age-Related Macular Degeneration Claire McKeague A thesis submitted to Cardiff University for the degree of Master of Philosophy SCHOOL OF OPTOMETRY AND VISION SCIENCES, CARDIFF UNIVERSITY 2014 SUPERVISED BY DR ALISON BINNS & DR TOM MARGRAIN DECLARATION This work has not previously been accepted in substance for any degree and is not concurrently submitted in candidature for any degree. STATEMENT 1 This thesis is being submitted in partial fulfillment of the requirements for the degree of …………………………(insert MCh, MD, MPhil, PhD etc, as appropriate) STATEMENT 2 This thesis is the result of my own independent work/investigation, except where otherwise stated. Other sources are acknowledged by explicit references. STATEMENT 3 I hereby give consent for my thesis, if accepted, to be available for photocopying and for inter- library loan, and for the title and summary to be made available to outside organisations. Summary Age-related macular degeneration (AMD) is the leading cause of blindness amongst older adults in the developed world. With the predicted rise in the ageing population over the next decades, the prevalence of this debilitating disease will simply continue to increase. The only treatments currently available are for advanced neovascular AMD. The retina is already severely compromised by this stage in disease development. Therefore, there is a pressing need to evaluate potential novel interventions that aim to prevent the development of advanced disease in people with early AMD, to prevent sight loss from occurring. Furthermore, it is necessary to develop tests that are sensitive to subtle changes in visual function in order to evaluate the efficacy of these emerging treatments.
    [Show full text]
  • B.Voc in Optometry B.Voc (OPT) Year -1 Diploma
    B.Voc in Optometry B.Voc (OPT) Year -1 Diploma I Semester S.No. Course Code Subject Content Credit Type 1 BVOPT-101 General Human Anatomy & Physiology General 4 2 BVOPT-102 General biochemistry Skill 4 3 BVOPT-103 Geometrical optics-I Skill 4 4 BVOPT-104 Medical Ethics and Patients Care General 3 5 BVOPT-105 Fundamental of Computers General 3 6 BVOPT-106 General English and soft skill General 2 BVOPTP-101 Practical of CourseBVOPT-101 Skill 2 BVOPTP-102 Practical of CourseBVOPT-102 Skill 2 BVOPTP-103 Practical of CourseBVOPT-103 Skill 2 BVOPTP-104 Practical of CourseBVOPT-104 Skill 2 BVOPTP-105 Practical of CourseBVOPT-105 Skill 2 II Semester S.No. Course Code Subject Type of Credits Course 1 BVOPT-201 Ocular Anatomy and physiology Gen 4 2 BVOPT-202 Physical optics Skill 4 3 BVOPT-203 Geometrical optics II Skill 4 4 BVOPT-204 Optometric Optics –I Skill 2 5 BVOPT-205 Orientation in para clinic science General 3 6 BVOPT-206 Basics of Health Market & Economy General 3 BVOPTP-201 Practical of Course BVOPT-201 Skill 2 BVOPTP-202 Practical of Course BVOPT202 Skill 2 BVOPTP-203 Practical of Course BVOPT-203 Skill 2 BVOPTP-204 Practical of Course BVOPT-204 Skill 2 BVOPTP-205 Practical of Course BVOPT-205 Skill 2 Internship in Hospital B.Voc in Optometry B.Voc (OPT) Year -2Advance Diploma III Semester S.No. Course Code Subject Type of Credits Course 1 BVOPT-301 General and ocular microbiology Gen 4 2 BVOPT-302 Visual Optics- I Skill 3 3 BVOPT-303 Optometric Optics – II Skill 4 4 BVOPT-304 Optometric Instruments Skill 3 5 BVOPT-305 Advance Computing skills Gen 2 6 BVOPT-306 Human Values & Professional Ethics Gen 4 BVOPTP-301 Practical based on BVOPT-301 Skill 2 BVOPTP-302 Practical based on BVOPT-302 Skill 2 BVOPTP-303 Practical based on BVOPT-303 Skill 2 BVOPTP-304 Practical based on BVOPT-304 Skill 2 BVOPTP-305 Practical based on BVOPT-305 Skill 2 IV Semester S.No.
    [Show full text]
  • Photostress Test As a Predictor of Macular Dysfunction in Patients with Asymmetrical Age-Related Maculopathy
    Original Research Article DOI: 10.18231/2395-1451.2017.0017 Photostress test as a predictor of macular dysfunction in patients with asymmetrical Age-related maculopathy Bindu S1,*, Jyothi PT2, Padma B. Prabhu3, Sandhya S4 1,3Associate Professor, 2Professor, 4Assistant Professor, Dept. of Ophthalmology, Govt. Medical College, Kozhikode, Kerala *Corresponding Author: Email: [email protected] Abstract Background: Age related maculopathy causes irreversible central visual loss in elderly population. Photo stress recovery time and Amsler grid evaluation are the tests used to assess the functional integrity of macula. Aim of Study: 1. To determine the Photo stress recovery time (PSRT) in patients with asymmetrical age-related macular maculopathy (ARM) 2. To find out the prevalence and the relation between risk factors, visual acuity, Amsler evaluation and photo stress recovery time. Settings and Design: Hospital based Case series study. Materials and Methods: Out of the 2104 participants above 50years, 37 patients presented with features of age related maculopathy. The systemic and ocular risk factors of ARM was observed. Relevant clinical examination, photo stress test and amsler grid monitoring was done in all patients. Statistical analysis was done using SPSS Version 18. Results: The overall prevalence of age related maculopathy in the study population was 1.76%, and it increases with age. Mean age was 62.84 years ± 7.97. Males were more affected by the disease. Smoking, dyslipidemia, cortical cataract and hyperopia were the most common risk factors. Photo stress recovery time was prolonged in all patients with reduced visual acuity. Even in eyes with good vision it was abnormal in the early stage of the disease before visible change occurred in the macula.
    [Show full text]
  • Dr. Madhura Mali ABSTRACT KEYWORDS INTERNATIONAL
    ORIGINAL RESEARCH PAPER Volume-8 | Issue-7 | July - 2019 | PRINT ISSN No. 2277 - 8179 INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH USE OF PHOTOSTRESS TEST TO STUDY MACULAR FUNCTION IN EYES WITH MACULOPATHIES Ophthalmology Assistant Professor, Department of Ophthalmology, SMT. Kashibai Navale Medical Dr. Madhura Mali College, Pune ABSTRACT Introduction: There are various Psychophysical and Electrophysiological tests to evaluate macular functions. In present era of technology driven diagnostic testing, there is lesser utilization of simpler and cost effective clinical tests. This study was undertaken to evaluate macular function by Photostress test in eyes with and without Maculopathies. Aim: Study various Maculopathies using Photostress test. Methodology: This study was conducted on 389 eyes with maculopathies and 400 normal eyes. A detailed ophthalmic and macular examination with Photostress test was performed in all cases. Results: Maculopathy was commonly observed in age group of 41 to 50 years with a higher prevalence amongst males. 18 types of maculopathies were found in the study, Dry ARMD(25.15%) and Diabetic Maculopathy(8.9%) were most common. Photostress test was positive in 46 out of 389 eyes with maculopathies (11.83%). Conclusion: Photostress test is an useful indicator in early diagnosis of Maculopathies. KEYWORDS Macula, Photostress test, Maculopathy INTRODUCTION the PSRT. Normal range is upto 40 seconds. PSRT increases with age The photoreceptors of the macular area of the retina are responsible for but is independent of pupil size, ametropia and visual acuity.[4] Despite photopic and colour vision. Disturbances in anatomical integrity of the the fact that it is easy to perform and is readily available for clinical use, macula by oedema, inflammation or degeneration results in it is underutilized.
    [Show full text]
  • Psychophysical Function in Age-Related Maculopathy Kumari Neelam, FRCS,1,2,3 John Nolan, Phd,1 Usha Chakravarthy, Phd,4 and Stephen Beatty, MD1,2
    SURVEY OF OPHTHALMOLOGY VOLUME 54 NUMBER 2 MARCH–APRIL 2009 MAJOR REVIEW Psychophysical Function in Age-related Maculopathy Kumari Neelam, FRCS,1,2,3 John Nolan, PhD,1 Usha Chakravarthy, PhD,4 and Stephen Beatty, MD1,2 1Waterford Institute of Technology, Waterford, Republic of Ireland; 2Waterford Regional Hospital, Waterford, Republic of Ireland; 3Alexandra Hospital, National Healthcare Group, Singapore; and 4Queen’s University and Royal Victoria Hospitals, Belfast, United Kingdom Abstract. Age-related macular degeneration (AMD), the late stage of age-related maculopathy (ARM), is the leading cause of blind registration in developed countries. The visual loss in AMD occurs due to dysfunction and death of photoreceptors (rods and cones) secondary to an atrophic or a neovascular event. The psychophysical tests of vision, which depend on the functional status of the photoreceptors, may detect subtle alterations in the macula before morphological fundus changes are apparent ophthalmoscopically, and before traditional measures of visual acuity exhibit deterioration, and may be a useful tool for assessing and monitoring patients with ARM. Furthermore, worsening of these visual functions over time may reflect disease progression, and some of these, alone or in combination with other parameters, may act as a prognostic indicator for identifying eyes at risk for developing neovascular AMD. Lastly, psychophysical tests often correlate with subjective and relatively undefined symptoms in patients with early ARM, and may reflect limitation of daily activities for ARM patients. However, clinical studies investigating psychophysical function have largely been cross- sectional in nature, with small sample sizes, and lack consistency in terms of the grading and classification of ARM.
    [Show full text]
  • Photostress Recovery in Chronic Open Angle Glaucoma
    Br J Ophthalmol: first published as 10.1136/bjo.72.9.641 on 1 September 1988. Downloaded from British Journal of Ophthalmology, 1988, 72, 641-645 Photostress recovery in chronic open angle glaucoma MARK D SHERMAN AND PAUL HENKIND* From the Department ofOphthalmology, Albert Einstein College ofMedicine and Montefiore Medical Center, Bronx, New York, USA SUMMARY Photostress recovery time was measured in 30 eyes from 15 patients with chronic open angle glaucoma, and 30 eyes from 15 individuals of a similar age group with no ophthalmological disorder. The average recovery time in patients with glaucoma was 70 47 (SD 35-39) seconds. The average recovery time in the control population was 41-97 (SD 17.34) seconds. This difference was statistically significant (p<O0OO1). There was a small positive correlation between age and recovery time in the control population, whereas there was no correlation between age and recovery time in the glaucoma group. There was no correlation between visual acuity and recovery time for either group. There was also no correlation between intraocular pressure and recovery time for the glaucoma group. It was not possible to control for pupillary dilatation in this study. However, it has been previously demonstrated that pharmacological meiosis will not delay photostress recovery time in normal subjects. This is the first report of photostress recovery testing in patients with chronic open angle glaucoma. The results are discussed in terms of the pathophysiology of glaucoma and previous photostress studies in patients with macular disease. copyright. Photostress recovery time (PSRT) has frequently the time required for the eye to return to baseline been used as a quantitative measure of macular visual acuity once the illumination period is over.
    [Show full text]
  • Suitability and Repeatability of a Photostress Recovery Test Device, the Macular Degeneration Detector (MDD-2), for Diabetes and Diabetic Retinopathy Assessment
    Technological University Dublin ARROW@TU Dublin Articles 2013 Suitability and Repeatability of a Photostress Recovery Test Device, the Macular Degeneration Detector (MDD-2), for Diabetes and Diabetic Retinopathy Assessment James Loughman Technological University Dublin, [email protected] Matthew Ratzlaff University of KwaZulu-Natal Brittany Foerg Mater Misericordiae University Hospital, Dublin See next page for additional authors Follow this and additional works at: https://arrow.tudublin.ie/otpomart Part of the Optometry Commons Recommended Citation Loughman, J., Ratzlaff, M., Foerg, B., Connell, P.:Suitability and Repeatability of a Photostress Recovery Test Device, the Macular Degeneration Detector (MDD-2), for Diabetes and Diabetic Retinopathy Assessment. Retina, 2013. This Article is brought to you for free and open access by ARROW@TU Dublin. It has been accepted for inclusion in Articles by an authorized administrator of ARROW@TU Dublin. For more information, please contact [email protected], [email protected]. This work is licensed under a Creative Commons Attribution-Noncommercial-Share Alike 4.0 License Authors James Loughman, Matthew Ratzlaff, Brittany Foerg, and Paul Connell This article is available at ARROW@TU Dublin: https://arrow.tudublin.ie/otpomart/35 SUITABILITY AND REPEATABILITY OF A PHOTOSTRESS RECOVERY TEST DEVICE, THE MACULAR DEGENERATION DETECTOR (MDD-2), FOR DIABETES AND DIABETIC RETINOPATHY ASSESSMENT JAMES LOUGHMAN, PHD,*† MATTHEW RATZLAFF, BSC,‡ BRITTANY FOERG, BSC,* PAUL CONNELL, MD‡ Background: Diabetic retinopathy can result in impaired photostress recovery time despite normal visual acuity and fundoscopic appearance. The Macular Degeneration Detector (MDD-2) is a novel flash photostress recovery time device. In this study, we examine the repeatability of the MDD-2 in normal and diabetic subjects.
    [Show full text]
  • Submitted in Partial Fulfillment of Requirements Of
    DISSERTATION ON A CLINICAL STUDY ON CYSTOID MACULAR EDEMA DUE TO VEIN OCCLUSION AND ITS MANAGEMENT Submitted in partial fulfillment of requirements of M.S.OPHTHALMOLOGY BRANCH – III REGIONAL INSTITUTE OF OPHTHALMOLOGY MADRAS MEDICAL COLLEGE CHENNAI – 600 008 THE TAMIL NADU DR.M.G.R.MEDICAL UNIVESITY CHENNAI APRIL 2017 CERTIFICATE This is to certify that the dissertation titled, “A CLINICALSTUDY ON CYSTOID MACULAR EDEMA DUE TO VEIN OCCLUSION AND ITS MANAGEMENT is a bonafide record ofthe research work done by DR.SHALINI. S, post graduate in the RegionalInstitute of Ophthalmology & Government Ophthalmic Hospital, MadrasMedical College and Research Institute,Chennai-08,submitted in partialfulfillment of the regulations laid down by the Tamil Nadu Dr. M.G.R.Medical University, Chennai for the award of M.S.OphthalmologyBranch III, under my guidance and supervision during the academic years2014 - 2017 Prof. Dr. M Rajakumari MS. Prof. Dr.WaheedaNazir., MS.DO Head of the department, Director and Superintendent Uvea and Retina services, Regional institute of ophthalmology Regional institute of ophthalmology, Government ophthalmic hospital Government ophthalmic hospital, Madras medical college Madras medical college, chennai-8. Chennai 8 PROF. DR.M . K MURALIDHARAN, M.S MCH., DEAN n Madras Medical College & Government General Hospital, Chennai – 600 003 DECLARATION BY THE CANDIDATE I hereby declare this dissertation entitled “A CLINICAL STUDYON CYSTOID MACULAR EDEMADUE TO VEIN OCCLUSION AND ITS MANAGEMENT is a bonafide and genuineresearch work carried out by me under the guidance ofProf.Dr. M RajakumariM.S , D.O DATE : PLACE DR. SHALINI.S ACKNOWLEDGEMENT I express my sincere thanks and gratitude toProf.Dr.M K Muralidharan.
    [Show full text]
  • Symbols and Abbrevations
    City Research Online City, University of London Institutional Repository Citation: Vemala, R. (2018). Loss of chromatic sensitivity in patients with age-related maculopathy - correlation with structural changes in the retina. (Unpublished Doctoral thesis, City, University of London) This is the accepted version of the paper. This version of the publication may differ from the final published version. Permanent repository link: https://openaccess.city.ac.uk/id/eprint/26212/ Link to published version: Copyright: City Research Online aims to make research outputs of City, University of London available to a wider audience. Copyright and Moral Rights remain with the author(s) and/or copyright holders. URLs from City Research Online may be freely distributed and linked to. Reuse: Copies of full items can be used for personal research or study, educational, or not-for-profit purposes without prior permission or charge. Provided that the authors, title and full bibliographic details are credited, a hyperlink and/or URL is given for the original metadata page and the content is not changed in any way. City Research Online: http://openaccess.city.ac.uk/ [email protected] Loss of chromatic sensitivity in patients with age-related maculopathy - correlation with structural changes in the retina Mrs Roopa Vemala Doctor of Philosophy Applied Vision Research Centre School of Health Sciences City, University of London January 2018 CONTENTS Table of Contents TABLE OF FIGURES: ................................................................................................................................
    [Show full text]